Concepedia

Thomas S.K. Gilbert

TS

18

Publications

923

Citations

16

H-Index

2016

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Translational Genomics Research Institute

Harvard University

Finland University

Thomas S.K. Gilbert is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCancer ResearchSystems BiologyCell SignalingMolecular BiologyRadiation OncologyOncologyCell Death

Publications per year

2016–2023

18

Publications

18

Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

Paul R. Graves, Lucas J. Aponte‐Collazo, Emily M.J. Fennell et al. · ACS Chemical Biology · 2019 · 195 citations

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert et al. · Cancer Cell · 2018 · 186 citations · Full text

Reductive Stress, Signal Transduction, Biochemistry +13

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George et al. · Cell Reports · 2020 · 97 citations · Full text

Kras Mutant Cancers, Apoptosis, Cell Death +19

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer

Devon R. Blake, Angelina V. Vaseva, Richard G. Hodge et al. · Science Signaling · 2019 · 70 citations · Full text

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith et al. · PLoS ONE · 2021 · 49 citations · Full text

Rows per page

1–5 of 18